|
1. Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol. 1998; 81(5 Pt 2):478-518. doi: 10.1016/s1081-1206(10)63155-9 PMID: 9860027 2. Tahamiler R, Edizer DT, Canakcioglu S, Guvenc MG, Inci E, Dirican A. Nasal sound analysis: a new method for evaluating nasal obstruction in allergic rhinitis. Laryngoscope. 2006; 116(11):2050-4. doi: 10.1097/01.mlg.0000240173.74885.0d PMID: 17075412 3. Marshall PS, O'Hara C, Steinberg P. Effects of seasonal allergic rhinitis on selected cognitive abilities. Ann Allergy Asthma Immunol. 2000; 84(4):403-10. doi: 10.1016/S1081-1206(10)62273-9 PMID: 10795648 4. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001; 108(5 Suppl):S147-334. doi: 10.1067/mai.2001.118891 PMID: 11707753 5. Day JH, Briscoe MP, Rafeiro E, Ratz JD. Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). Int J Clin Pract 2004; 58(2):109-18. doi: 10.1111/j.1368-5031.2004.0117.x PMID: 15055856 6. Meltzer EO, Prenner BM, Nayak A. Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H 1-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis. Clinical Drug Investigation. 2001; 21:25-32. doi: 10.2165/00044011-200121010-00004. 7. Patel P, Philip G, Yang W, Call R, Horak F, LaForce C, Gilles L, Garrett GC, Dass SB, Knorr BA, Reiss TF. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2005; 95(6):551-7. doi: 10.1016/S1081-1206(10)61018-6 PMID: 16400895 8. Cingi C, Oghan F, Eskiizmir G, Yaz A, Ural A, Erdogmus N. Desloratadine-montelukast combination improves quality of life and decreases nasal obstruction in patients with perennial allergic rhinitis. Int Forum Allergy Rhinol 2013; 3(10): 801-6. doi: 10.1002/alr.21185 PMID: 23733270 9. Ciebiada M, Barylski M, Gorska Ciebiada M. Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine. Am J Rhinol Allergy. 2013; 27(2): e58-62. doi: 10.2500/ajra.2013.27.3881 PMID: 23562192 10. Erdoğan BA, Sanlı A, Paksoy M, Altın G, Aydın S. Quality of life in patients with persistent allergic rhinitis treated with desloratadine monotherapy or desloratadine plus montelucast combination. Kulak Burun Bogaz Ihtis Derg 2014; 24(4):217-24. doi: 10.5606/kbbihtisas.2014.48108 PMID: 25046070 11. Ciebiada M, Ciebiada MG, Kmiecik T, DuBuske LM, Gorski P. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. J Investig Allergol Clin Immunol. 2008; 18(5):343-9. PMID: 18973097 12. Montelukast Sodium. [March, 6, 2020; cited]; Available from: https://www.drugs.com/monograph/montelukast-sodium.html 13. Kazmi F, Yerino P, Barbara JE, Parkinson A. Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor. Drug Metab Dispos. 2015; 43(9):1294-302. doi: 10.1124/dmd.115.065011 PMID: 26135009 14. Nayak AS, Philip G, Lu S, Malice MP, Reiss TF. Montelukast Fall Rhinitis Investigator Group. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol. 2002;88(6):592-600. doi: 10.1016/S1081-1206(10)61891-1 PMID: 12086367 15. Bachert C. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. Allergy. 2001;56 Suppl 65:14-20. doi: 10.1034/j.1398-9995.2001.00102.x PMID: 11243500 16. Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. 2000; 105(5):917-22. doi: 10.1067/mai.2000.106040 PMID: 10808172
|
.png){kind=logo}
